A detailed history of Invesco Ltd. transactions in Evolus, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 101,398 shares of EOLS stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
101,398
Previous 17,278 486.86%
Holding current value
$1.28 Million
Previous $187,000 778.07%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.66 - $17.48 $896,719 - $1.47 Million
84,120 Added 486.86%
101,398 $1.64 Million
Q2 2024

Aug 13, 2024

SELL
$10.45 - $13.76 $850,076 - $1.12 Million
-81,347 Reduced 82.48%
17,278 $187,000
Q1 2024

May 14, 2024

BUY
$9.99 - $14.91 $841,777 - $1.26 Million
84,262 Added 586.66%
98,625 $1.38 Million
Q4 2023

Feb 12, 2024

SELL
$7.6 - $10.53 $19,942 - $27,630
-2,624 Reduced 15.45%
14,363 $151,000
Q3 2023

Nov 13, 2023

BUY
$7.15 - $10.2 $1,844 - $2,631
258 Added 1.54%
16,987 $155,000
Q2 2023

Aug 11, 2023

BUY
$7.23 - $10.52 $5,928 - $8,626
820 Added 5.15%
16,729 $121,000
Q1 2023

May 12, 2023

BUY
$7.81 - $11.05 $4,428 - $6,265
567 Added 3.7%
15,909 $134,000
Q4 2022

Feb 13, 2023

SELL
$6.52 - $8.95 $997,044 - $1.37 Million
-152,921 Reduced 90.88%
15,342 $115,000
Q3 2022

Nov 14, 2022

BUY
$7.76 - $13.72 $251,788 - $445,172
32,447 Added 23.89%
168,263 $1.36 Million
Q2 2022

Aug 15, 2022

SELL
$10.22 - $13.94 $128,792 - $175,671
-12,602 Reduced 8.49%
135,816 $1.58 Million
Q1 2022

May 16, 2022

BUY
$5.22 - $11.78 $710,749 - $1.6 Million
136,159 Added 1110.69%
148,418 $1.67 Million
Q4 2021

Feb 14, 2022

BUY
$5.37 - $8.38 $3,656 - $5,706
681 Added 5.88%
12,259 $80,000
Q3 2021

Nov 15, 2021

SELL
$7.36 - $13.67 $1.04 Million - $1.93 Million
-141,492 Reduced 92.44%
11,578 $88,000
Q2 2021

Aug 17, 2021

SELL
$8.42 - $13.96 $3.43 Million - $5.69 Million
-407,354 Reduced 72.69%
153,070 $1.94 Million
Q1 2021

May 17, 2021

BUY
$3.2 - $16.51 $1.79 Million - $9.25 Million
560,424 New
560,424 $7.28 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $707M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.